Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli…
Denmark slashes 2025 growth forecast amid Novo Nordisk slowdown
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
European pharma secured a U.S. tariff win. Investors remain wary
European pharmaceutical firms gained some much-desired clarity on Thursday, with news that U.S. tariffs will be capped at…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…
We’re downgrading Lilly and asking ourselves tough questions after its obesity pill letdown
Eli Lilly delivered strong second-quarter results on Thursday, but shares are plummeting because of disappointing data for a…
Eli Lilly obesity pill orforglipron led to 12% weight loss
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Hims & Hers (HIMS) Q2 earnings 2025
The Hers app arranged on a smartphone in New York on Feb. 12, 2025. Gabby Jones | Bloomberg…
Trump asks drugmakers to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz,…
Novo Nordisk gets a downgrade from Bank of America as Wegovy growth outlook weakens
Concerns over Novo Nordisk’s growth path is leading Bank of America to step to the sidelines. The bank…
Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the…
It’s all about the guidance
Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left…